Centre identifies 75 tribal districts for focused TB interventions
- August 27, 2022
- Posted by: OptimizeIAS Team
- Category: DPN Topics
No Comments
Centre identifies 75 tribal districts for focused TB interventions
Subject :Government Schemes
Section: Health
Aashwasan Campaign
- The campaign to detect TB cases across 174 tribal districts started this January under the Aashwasan Campaign, under which door-to-door screening was done in over 68,000 villages. Official data showed that 3,82,811 people were identified for presumptive TB after a verbal screening of over 1.03 crore people in these villages.
- The Aashwasan Campaign was undertaken by the Tribal Affairs and Health Ministries and supported by USAID (United States Agency for International Development) as a technical partner and Piramal Swasthya as the implementing partner.
Steps Taken by India:
- India has committed to eliminating TB in the country by 2025.
- Five years ahead of the global deadline of 2030.
- National Strategy Plan for TB Elimination 2017-2025:
- The requirements for moving towards TB elimination in India have been arranged in four strategic areas of Detect, Treat, Prevent & Build.
- There is also across all four areas, an overarching theme of the Private Sector. Another overarching theme is that of Key Populations.
- TB Harega Desh Jeetega Campaign, Nikshay Poshan Yojana, etc.
Global Efforts:
- The End TB Strategy of WHO.
- World Tuberculosis (TB) Day is observed on 24th March to raise public awareness about the devastating health, social and economic consequences of TB.
Nikshay Poshan Yojana (NPY)
- The NPY was launched in 2018 by the Ministry of Health and Family Welfare.
- It aims to support every Tuberculosis (TB) Patient by providing a Direct Benefit Transfer (DBT) of Rs 500 per month for nutritional needs.
The Saksham Project
- It is a project of the Tata Institute of Social Sciences (TISS) that has been providing psycho-social counselling to DR-TB patients.
Tuberculosis
- Tuberculosis is caused by bacteria (Mycobacterium tuberculosis) that most often affect the lungs.
- Transmission: TB is spread from person to person through the air. When people with lung TB cough, sneeze or spit, they propel the TB germs into the air.
- Symptoms: Cough with sputum and blood at times, chest pains, weakness, weight loss, fever and night sweats.
- Treatment: TB is treatable and curable disease. It is treated with a standard 6 month course of 4 antimicrobial drugs that are provided with information, supervision and support to the patient by a health worker or trained volunteer.
- Multidrug-resistant TB (MDR-TB) is a form of TB caused by bacteria that do not respond to isoniazid and rifampicin, the 2 most powerful, first-line anti-TB drugs. MDR-TB is treatable and curable by using second-line drugs.
- Extensively drug resistant TB (XDR TB) is a rare type of MDR TB that is resistant to isoniazid and rifampin, plus any fluoroquinolone and at least one of three injectable second-line drugs (i.e., amikacin, kanamycin, or capreomycin).